Interleukin‐13: Targeting an underestimated cytokine in atopic dermatitis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin‐13: Targeting an underestimated cytokine in atopic dermatitis
Authors
Keywords
-
Journal
ALLERGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-06-23
DOI
10.1111/all.13954
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Atopic dermatitis is an IL-13 dominant disease with greater molecular heterogeneity compared to psoriasis
- (2019) Lam C. Tsoi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Janus kinases to jakinibs: from basic insights to clinical practice
- (2019) Massimo Gadina et al. RHEUMATOLOGY
- Use of dupilimab in pediatric atopic dermatitis: Access, dosing, and implications for managing severe atopic dermatitis
- (2019) Elaine C. Siegfried et al. PEDIATRIC DERMATOLOGY
- Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb
- (2018) Andreas Wollenberg et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Emerging therapies for atopic dermatitis: JAK inhibitors
- (2018) David G. Cotter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dupilumab: A review of its use in the treatment of atopic dermatitis
- (2018) Melinda J. Gooderham et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
- (2018) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tuning the Cytokine Responses: An Update on Interleukin (IL)-4 and IL-13 Receptor Complexes
- (2018) Ilkka S. Junttila Frontiers in Immunology
- Atopic dermatitis
- (2018) Stephan Weidinger et al. Nature Reviews Disease Primers
- Modulating Interleukins and their receptors interactions with small chemicals using in silico approach for asthma
- (2018) Sreyashi Majumdar et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Oral small molecules for the treatment of atopic dermatitis: a systematic review
- (2018) Pezhman Mobasher et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Commonality of the IL-4/IL-13 pathway in atopic diseases
- (2017) Namita A. Gandhi et al. Expert Review of Clinical Immunology
- SPINK5 is associated with early-onset and CHI3L1 with late-onset atopic dermatitis
- (2017) K. Dežman et al. International Journal of Immunogenetics
- Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go?
- (2017) Thomas Bieber et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Increased frequencies of basophils, type 2 innate lymphoid cells and Th2 cells in skin of patients with atopic dermatitis but not psoriasis
- (2017) Shunya Mashiko et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Skin Colonization by Staphylococcus aureus Precedes the Clinical Diagnosis of Atopic Dermatitis in Infancy
- (2017) Patrick Meylan et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the Disease
- (2017) Benjamin Ungar et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2
- (2017) B. Popovic et al. JOURNAL OF MOLECULAR BIOLOGY
- Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis
- (2017) Teruaki Nakatsuji et al. Science Translational Medicine
- Phenotypes of Atopic Dermatitis Depending on the Timing of Onset and Progression in Childhood
- (2017) Caroline Roduit et al. JAMA Pediatrics
- Chitinase-3-Like Protein 1 (YKL-40) Reflects the Severity of Symptoms in Atopic Dermatitis
- (2017) Joanna Salomon et al. Journal of Immunology Research
- Atopic dermatitis phenotype with early onset and high serum IL-13 is linked to the new development of bronchial hyperresponsiveness in school children
- (2016) E. Lee et al. ALLERGY
- Stratum Corneum Tape Stripping: Monitoring of Inflammatory Mediators in Atopic Dermatitis Patients Using Topical Therapy
- (2016) Sjors A. Koppes et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma
- (2016) Diego Bagnasco et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis
- (2016) Claus Bachert et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Skin barrier impairment at birth predicts food allergy at 2 years of age
- (2016) Maeve M. Kelleher et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity
- (2016) Sean P. Saunders et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Influence of Th2 Cytokines on the Cornified Envelope, Tight Junction Proteins, and β-Defensins in Filaggrin-Deficient Skin Equivalents
- (2016) Stefan Hönzke et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)
- (2016) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults
- (2016) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Atopic dermatitis
- (2016) Stephan Weidinger et al. LANCET
- Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
- (2016) Diamant Thaçi et al. LANCET
- A mechanistic PK/PD model for two anti-IL13 antibodies explains the difference in total IL-13 accumulation observed in clinical studies
- (2016) Abhinav Tiwari et al. mAbs
- Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
- (2016) Duncan E. Scott et al. NATURE REVIEWS DRUG DISCOVERY
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2016) Eric L. Simpson et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Player and Coordinator: The Versatile Roles of Eosinophils in the Immune System
- (2016) Hai Long et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics
- (2016) Steven O’Reilly et al. Scientific Reports
- Transepidermal water loss measurement during infancy can predict the subsequent development of atopic dermatitis regardless of filaggrin mutations
- (2016) Kenta Horimukai et al. ALLERGOLOGY INTERNATIONAL
- Commentary: IL-4 and IL-13 receptors and signaling
- (2015) Sarah M. McCormick et al. CYTOKINE
- The differential expression of IL-4 and IL-13 and its impact on type-2 immunity
- (2015) Katherine Bao et al. CYTOKINE
- Strategies targeting the IL-4/IL-13 axes in disease
- (2015) Richard D. May et al. CYTOKINE
- Barrier Epithelial Cells and the Control of Type 2 Immunity
- (2015) Hamida Hammad et al. IMMUNITY
- Drug evaluation review: dupilumab in atopic dermatitis
- (2015) Jennifer D Hamilton et al. Immunotherapy
- Cytokine profiles in interstitial fluid from chronic atopic dermatitis skin
- (2015) K. Szegedi et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Targeting key proximal drivers of type 2 inflammation in disease
- (2015) Namita A. Gandhi et al. NATURE REVIEWS DRUG DISCOVERY
- Type I/II cytokines, JAKs and new strategies for treating autoimmune diseases
- (2015) Daniella M. Schwartz et al. Nature Reviews Rheumatology
- Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
- (2014) Michelle R. Arkin et al. CHEMISTRY & BIOLOGY
- The messenger between worlds: the regulation of innate and adaptive type-2 immunity by innate lymphoid cells
- (2014) S. T. Scanlon et al. CLINICAL AND EXPERIMENTAL ALLERGY
- TNF-α/IL-17 synergy inhibits IL-13 bioactivity via IL-13Rα2 induction
- (2014) Vahe Badalyan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Transgenic kallikrein 5 mice reproduce major cutaneous and systemic hallmarks of Netherton syndrome
- (2014) Laetitia Furio et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TNF-α and Th2 Cytokines Induce Atopic Dermatitis–Like Features on Epidermal Differentiation Proteins and Stratum Corneum Lipids in Human Skin Equivalents
- (2014) Mogbekeloluwa O. Danso et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Defective basement membrane in atopic dermatitis and possible role of IL-13
- (2014) J.W. Shin et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
- (2014) Lisa A. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Developmental Profiles of Eczema, Wheeze, and Rhinitis: Two Population-Based Birth Cohort Studies
- (2014) Danielle C. M. Belgrave et al. PLOS MEDICINE
- Netherton syndrome: skin inflammation and allergy by loss of protease inhibition
- (2013) Alain Hovnanian CELL AND TISSUE RESEARCH
- A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis
- (2013) Stephan Weidinger et al. HUMAN MOLECULAR GENETICS
- Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin
- (2013) Laurence Pellerin et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis
- (2013) Maryam Salimi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TRPA1-Dependent Pruritus in IL-13-Induced Chronic Atopic Dermatitis
- (2013) M.-H. Oh et al. JOURNAL OF IMMUNOLOGY
- Structural Basis of Signaling Blockade by Anti-IL-13 Antibody Lebrikizumab
- (2013) Mark Ultsch et al. JOURNAL OF MOLECULAR BIOLOGY
- The association of the cytoplasmic domains of interleukin 4 receptor alpha and interleukin 13 receptor alpha 2 regulates interleukin 4 signaling
- (2013) Allison-Lynn Andrews et al. Molecular BioSystems
- Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
- (2013) Sally Wenzel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chitinase 3-like 1 Regulates Cellular and Tissue Responses via IL-13 Receptor α2
- (2013) Chuan Hua He et al. Cell Reports
- IL-13 Induces Skin Fibrosis in Atopic Dermatitis by Thymic Stromal Lymphopoietin
- (2011) M.-H. Oh et al. JOURNAL OF IMMUNOLOGY
- Lebrikizumab Treatment in Adults with Asthma
- (2011) Jonathan Corren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of Matrix Metalloproteinase-13 Is Controlled by IL-13 via PI3K/Akt3 and PKC-δ in Normal Human Dermal Fibroblasts
- (2010) Chikako Moriya et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Molecular Basis for Shared Cytokine Recognition Revealed in the Structure of an Unusually High Affinity Complex between IL-13 and IL-13Rα2
- (2010) Patrick J. Lupardus et al. STRUCTURE
- Cytokine modulation of atopic dermatitis filaggrin skin expression
- (2009) Michael D. Howell et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6
- (2008) Byung Eui Kim et al. CLINICAL IMMUNOLOGY
- Th2 Cytokines Act on S100/A11 to Downregulate Keratinocyte Differentiation
- (2008) Michael D. Howell et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Atopic Dermatitis
- (2008) Thomas Bieber NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started